| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 696.93M | 501.02M | 187.19M | 75.51M | 59.04M | 7.90M |
| Gross Profit | 355.33M | 342.03M | 100.13M | 36.09M | 51.59M | 5.68M |
| EBITDA | 748.55M | 201.69M | 31.21M | -9.83M | 8.14M | 729.00K |
| Net Income | 402.37M | 86.94M | -28.92M | -171.83M | -419.77M | -60.39M |
Balance Sheet | ||||||
| Total Assets | 7.03B | 2.94B | 1.15B | 332.07M | 392.28M | 100.95M |
| Cash, Cash Equivalents and Short-Term Investments | 3.26B | 564.53M | 411.13M | 68.89M | 75.62M | 29.27M |
| Total Debt | 3.84B | 964.23M | 1.32M | 1.45M | 108.29M | 62.93M |
| Total Liabilities | 4.52B | 1.12B | 55.35M | 26.71M | 133.10M | 138.09M |
| Stockholders Equity | 2.51B | 1.82B | 1.10B | 305.36M | 437.36M | -37.13M |
Cash Flow | ||||||
| Free Cash Flow | -259.56M | -1.13B | -427.19M | -110.02M | -272.69M | -4.13M |
| Operating Cash Flow | 564.80M | 245.89M | 52.22M | 5.73M | 21.56M | 1.31M |
| Investing Cash Flow | -2.11B | -1.38B | -498.47M | -71.47M | -318.12M | -60.69M |
| Financing Cash Flow | 4.37B | 1.29B | 782.13M | 28.56M | 372.04M | 88.04M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
61 Neutral | $521.12M | 1.58 | 22.65% | ― | 9.52% | 496.04% | |
54 Neutral | $5.36B | -6.51 | -21.05% | ― | 103.62% | 49.48% | |
54 Neutral | $5.93B | -6.85 | -107.05% | ― | 35.41% | -38.08% | |
52 Neutral | $2.51B | -1.90 | -13.75% | ― | 102.21% | ― | |
50 Neutral | $13.82B | -20.05 | 18.65% | ― | 236.14% | ― | |
43 Neutral | $946.16M | -9,981.68 | -2.75% | ― | ― | ― |
On March 4, 2026, IREN Limited expanded its at-the-market equity program by filing a new prospectus supplement that increases the potential offering of its ordinary shares to up to $6 billion under an amended and restated sales agreement with a broad syndicate of sales agents. The new filing replaces an August 28, 2025 prospectus supplement that had authorized up to $1 billion and under which the company has already sold 66,707,732 shares for total proceeds of $1 billion, positioning IREN to continue raising substantial equity capital and preserving flexibility to further adjust issuance capacity subject to board authorization and regulatory limits.
The most recent analyst rating on (IREN) stock is a Buy with a $51.00 price target. To see the full list of analyst forecasts on IREN stock, see the IREN Stock Forecast page.
On March 4, 2026, IREN subsidiaries in Canada and the U.S. signed purchase agreements with Dell units for roughly $3.5 billion of NVIDIA B300 GPUs and related hardware and services, to be delivered in tranches during the second half of 2026 and paid within 30 days of shipment. The parent company is providing unconditional guarantees on these obligations, a move that materially scales its hardware commitments while concentrating execution risk around timely deployment and customer uptake.
In a separate March 4, 2026 announcement, IREN said the new orders will lift its total fleet to about 150,000 GPUs, to be rolled out across existing data centers in Mackenzie, British Columbia, and Childress, Texas, with further capacity available at other locations. Backed by $9.3 billion of recently secured funding and an at-the-market equity program, the company plans around $3.5 billion of additional capex in the second half of 2026, positioning itself among the largest global AI cloud infrastructure providers and signaling an aggressive bid for market share in a supply-constrained GPU environment.
The most recent analyst rating on (IREN) stock is a Buy with a $51.00 price target. To see the full list of analyst forecasts on IREN stock, see the IREN Stock Forecast page.